A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Two Different Formulations of Long-acting Cabotegravir in Healthy Adult Participants
Clinical trial NCT06033547 · COMPLETED
Trial details
- NCT number
- NCT06033547
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-12
- Primary completion
- 2025-07-25
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.